Tonix Pharmaceuticals Ownership 2024 | Who Owns Tonix Pharmaceuticals Now?
Institutional Ownership
0.00%
Insider Ownership
1.69%
Retail Ownership
98.31%
Institutional Holders
1.00
Tonix Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
IFP ADVISORS, INC | - | - | - | -7 | -100.00% | - | Sep 30, 2023 |
Tonix Pharmaceuticals's largest institutional shareholder is IFP ADVISORS, INC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
IFP ADVISORS, INC | - | - | - | -7 | -100.00% | - | Sep 30, 2023 |
The largest Tonix Pharmaceuticals shareholder by % of total assets is IFP ADVISORS, INC. The company owns 0.00 shares of Tonix Pharmaceuticals (TNXP), representing 0.00% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
IFP ADVISORS, INC | - | - | - | -7 | -100.00% | - | Sep 30, 2023 |
As of Sep 30 2023, Tonix Pharmaceuticals's largest institutional buyer is IFP ADVISORS, INC. The company purchased -7.00 stocks of TNXP, valued at -.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
IFP ADVISORS, INC | - | - | - | -7 | -100.00% | - | Sep 30, 2023 |
As of Sep 30 2023, Tonix Pharmaceuticals's biggest institutional seller is IFP ADVISORS, INC. The company sold -7.00 shares of TNXP, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
IFP ADVISORS, INC | - | - | - | -7 | -100.00% | - | Sep 30, 2023 |
Tonix Pharmaceuticals's largest sold out institutional shareholder by shares sold is IFP ADVISORS, INC, sold -7.00 shares, valued at -, as of undefined.
Tonix Pharmaceuticals Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
BRIDGEWAY FUNDS INC | 0.08% | 200,000 | - | - | Dec 29, 2023 |
FIRST TRUST EXCHANGE-TRADED FUND VI | 0.04% | 172,793 | - | - | Dec 31, 2023 |
PRUDENTIAL INVESTMENT PORTFOLIOS, INC. | 0.02% | 226,100 | - | - | Dec 29, 2023 |
ETF Managers Trust | 0.02% | 150,526 | - | - | Dec 31, 2023 |
BRIDGEWAY FUNDS INC | 0.01% | 30,000 | - | - | Dec 29, 2023 |
VANGUARD INDEX FUNDS | 0.01% | 2,423,975 | - | - | Dec 31, 2023 |
Voya VARIABLE PORTFOLIOS INC | 0.00% | 123,963 | - | - | Dec 31, 2023 |
FIDELITY CONCORD STREET TRUST | 0.00% | 474,349 | - | - | Feb 29, 2024 |
ALPS ETF Trust | 0.00% | 15,012 | - | - | Feb 29, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 513,588 | 115,443 | 29.00% | Dec 31, 2023 |
T. Rowe Price Index Trust, Inc. | 0.00% | 18,961 | - | - | Feb 29, 2024 |
ETF Managers Trust | 0.00% | 5,922 | - | - | Dec 31, 2023 |
ADVANCED SERIES TRUST | 0.00% | 2,491,500 | - | - | Dec 29, 2023 |
PENN SERIES FUNDS INC | 0.00% | 12,100 | - | - | Dec 29, 2023 |
NORTHERN FUNDS | 0.00% | 289,039 | - | - | Dec 29, 2023 |
PRUDENTIAL INVESTMENT PORTFOLIOS 2 | 0.00% | 23,800 | - | - | Jan 31, 2024 |
VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 843 | - | - | Dec 31, 2023 |
MASSMUTUAL SELECT FUNDS | 0.00% | 38,738 | - | - | Dec 31, 2023 |
VANGUARD SCOTTSDALE FUNDS | 0.00% | 53,786 | - | - | Feb 29, 2024 |
MASTER INVESTMENT PORTFOLIO | 0.00% | 1,950 | - | - | Dec 31, 2023 |
VALIC Co I | 0.00% | 5,797 | - | - | Feb 29, 2024 |
Guggenheim Active Allocation Fund | 0.00% | 83 | - | - | Feb 29, 2024 |
Dimensional ETF Trust | 0.00% | 2,074 | - | - | Jan 31, 2024 |
MORGAN STANLEY PATHWAY FUNDS | 0.00% | 411 | - | - | Feb 29, 2024 |
iSHARES TRUST | 0.00% | 38,927 | - | - | Feb 29, 2024 |
JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 3,900 | - | - | Dec 31, 2023 |
RYDEX VARIABLE TRUST | 0.00% | - | - | - | Dec 31, 2023 |
Meeder Funds | 0.00% | 3 | - | - | Mar 31, 2024 |
RYDEX SERIES FUNDS | 0.00% | 1 | - | - | Dec 31, 2023 |
ProFunds | 0.00% | 1 | - | - | Jan 31, 2024 |
Tonix Pharmaceuticals's largest mutual fund holder by % of total assets is "BRIDGEWAY FUNDS INC", owning 200.00K shares, compromising 0.08% of its total assets.
Tonix Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
30 Jun, 23 | 1 | -97.06% |
31 Mar, 23 | 34 | -2.86% |
31 Dec, 22 | 35 | 45.83% |
30 Sep, 22 | 24 | -31.43% |
30 Jun, 22 | 35 | - |
As of 30 Jun 23, 1 institutions are holding Tonix Pharmaceuticals's shares, representing a decrease of -97.06% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
30 Jun, 23 | 7 | -100.00% |
31 Mar, 23 | 7,539,644 | -18.08% |
31 Dec, 22 | 9,203,923 | 65.21% |
30 Sep, 22 | 5,570,880 | 28.55% |
30 Jun, 22 | 4,333,760 | - |
Tonix Pharmaceuticals (TNXP) has 7.00 shares outstanding as of 30 Jun 23, down -100.00% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
30 Jun, 23 | 0.00% | - |
31 Mar, 23 | 74.38% | 0.90% |
31 Dec, 22 | 90.80% | 3.01% |
30 Sep, 22 | 54.96% | 3.01% |
30 Jun, 22 | 42.75% | - |
As of 30 Jun 23, Tonix Pharmaceuticals is held by 0.00% institutional shareholders, representing a 0.00% growth compared to 31 Mar 23.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
30 Jun, 23 | - | -100.00% |
31 Mar, 23 | 15 | -34.78% |
31 Dec, 22 | 23 | 43.75% |
30 Sep, 22 | 16 | -54.29% |
30 Jun, 22 | 35 | - |
- institutional shareholders have increased their position in TNXP stock as of 30 Jun 23 compared to 15 in the previous quarter (a -100.00% decrease).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
30 Jun, 23 | - | -100.00% |
31 Mar, 23 | 8 | - |
31 Dec, 22 | 8 | 100.00% |
30 Sep, 22 | 4 | - |
30 Jun, 22 | - | - |
- institutional shareholders have reduced their position in TNXP stock as of 30 Jun 23 compared to 8 in the previous quarter (a -100.00% decrease).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
30 Jun, 23 | 1 | -97.06% | 7 | -100.00% | 0.00% | - | - | -100.00% | - | -100.00% |
31 Mar, 23 | 34 | -2.86% | 7,539,644 | -18.08% | 74.38% | 0.90% | 15 | -34.78% | 8 | - |
31 Dec, 22 | 35 | 45.83% | 9,203,923 | 65.21% | 90.80% | 3.01% | 23 | 43.75% | 8 | 100.00% |
30 Sep, 22 | 24 | -31.43% | 5,570,880 | 28.55% | 54.96% | 3.01% | 16 | -54.29% | 4 | - |
30 Jun, 22 | 35 | - | 4,333,760 | - | 42.75% | - | 35 | - | - | - |
Tonix Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Open Market Insider Buys
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Insider Sells
All Insider Owners Trades
The last insider sell of Tonix Pharmaceuticals's stock was made by Stillwell Richard Newcomb on Mar 16 2023, selling 83,000 shares at $0.56 per share (valued at $46.65K).
Tonix Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q1 2024 | 9 | - | - |
Q2 2023 | 7 | - | - |
Q1 2023 | 9 | 1 | 900.00% |
Q2 2022 | 10 | - | - |
Q1 2022 | 17 | - | - |
Q4 2021 | - | - | - |
Q3 2021 | 2 | 1 | 200.00% |
Q2 2021 | 8 | 1 | 800.00% |
Q1 2021 | 10 | - | - |
Q4 2020 | 1 | - | - |
Q3 2020 | 7 | - | - |
Q2 2020 | 15 | 1 | 1500.00% |
Q1 2020 | 9 | - | - |
Q4 2019 | 1 | - | - |
Q2 2019 | 16 | 1 | 1600.00% |
Q1 2019 | 11 | 1 | 1100.00% |
Q3 2018 | 1 | 1 | 100.00% |
Q2 2018 | 19 | 1 | 1900.00% |
Q1 2018 | 11 | 2 | 550.00% |
Q4 2017 | 1 | 6 | 16.67% |
9 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Tonix Pharmaceuticals's insiders, as of Q1 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q1 2024 | - | - | - |
Q2 2023 | - | - | - |
Q1 2023 | - | - | - |
Q2 2022 | 1 | - | - |
Q1 2022 | 1 | - | - |
Q4 2021 | - | - | - |
Q3 2021 | 1 | - | - |
Q2 2021 | 1 | - | - |
Q1 2021 | 1 | - | - |
Q4 2020 | 1 | - | - |
Q3 2020 | 7 | - | - |
Q2 2020 | - | - | - |
Q1 2020 | - | - | - |
Q4 2019 | 1 | - | - |
Q2 2019 | - | - | - |
Q1 2019 | 2 | - | - |
Q3 2018 | - | - | - |
Q2 2018 | 11 | - | - |
Q1 2018 | - | - | - |
Q4 2017 | 1 | 6 | 16.67% |
As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Tonix Pharmaceuticals's stocks.
Tonix Pharmaceuticals Peer Ownership
Ticker | Company |
---|---|
VRAX | Virax Biolabs Group Limited |
CWBR | CohBar, Inc. |
JAGX | Jaguar Health, Inc. |
PALI | Palisade Bio, Inc. |
VBIV | VBI Vaccines Inc. |
DFFN | CervoMed Inc. |
VXRT | Vaxart, Inc. |
INO | Inovio Pharmaceuticals, Inc. |
ENVB | Enveric Biosciences, Inc. |
ONTX | Traws Pharma, Inc. |
ACST | Acasti Pharma Inc. |
NVAX | Novavax, Inc. |
SONN | Sonnet BioTherapeutics Holdings, Inc. |
DRUG | Bright Minds Biosciences Inc. |
TNXP Ownership FAQ
Who Owns Tonix Pharmaceuticals?
Tonix Pharmaceuticals is owned by institutional shareholders (0.00%), insiders (1.69%), and public (98.31%). The largest institutional shareholder of Tonix Pharmaceuticals is IFP ADVISORS, INC (0% of total shares) and the top mutual fund owner is BRIDGEWAY FUNDS INC (0.08% of total shares).
Who are the major institutional shareholders of Tonix Pharmaceuticals?
Tonix Pharmaceuticals's major institutional shareholders are IFP ADVISORS, INC. The top five shareholders own together 0% of the company's share outstanding.
How many Tonix Pharmaceuticals shareholders are there?
As of Jun 2023, there are 1 institutional shareholders of Tonix Pharmaceuticals.
What percentage of Tonix Pharmaceuticals is owned by IFP ADVISORS, INC?
IFP ADVISORS, INC owns 0 shares of Tonix Pharmaceuticals, representing 0% of the company's total shares outstanding, valued at $0 (as of Sep 2023).